Company Filing History:
Years Active: 2022
Title: Christopher Ronald Agee: Innovator in Onychomycosis Treatment
Introduction
Christopher Ronald Agee is a notable inventor based in Lake Forest, CA (US). He has made significant contributions to the field of medical treatments, particularly focusing on onychomycosis, a fungal infection affecting the nails. His innovative approach has led to the development of a unique treatment composition that addresses the challenges associated with this condition.
Latest Patents
Christopher Ronald Agee holds 1 patent for his invention titled "Onychomycosis treatment compositions and methods." This patent presents compositions and methods that provide substantially improved physical and pharmacological parameters for subungually administrable formulations. The compositions are designed to have a viscosity and film-forming capacity that retain the liquid formulation in sufficient quantities, aiding in the penetration of the polysaccharide matrix commonly associated with onychomycosis. The formulation is particularly beneficial as it allows for a high concentration of the active pharmaceutically active agent (API), promoting effective treatment while minimizing systemic absorption.
Career Highlights
Christopher is associated with Hallux Inc., where he continues to work on innovative solutions for nail health. His dedication to improving treatment options for onychomycosis has positioned him as a key figure in this specialized area of medical research.
Collaborations
Throughout his career, Christopher has collaborated with notable professionals, including Robert L. Orr and Thomas Mark Tremblay. These collaborations have contributed to the advancement of his research and the successful development of his patented treatment methods.
Conclusion
Christopher Ronald Agee's work in developing effective treatments for onychomycosis showcases his commitment to innovation in the medical field. His contributions are paving the way for improved patient outcomes in nail health.